Skip to content
WorldBrand.AI

CareFusion controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2014

    ChloraPrep promotion settlement

    The United States Department of Justice alleged that CareFusion promoted ChloraPrep for uses not approved by the FDA. CareFusion agreed to pay $40.1 million to resolve the matter. The case later received renewed scrutiny after the arrest of Jeffery Wertkin in 2017 in connection with allegations involving a sealed whistleblower complaint.

    Source